We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$182B
AUM Growth
+$5.26B
Cap. Flow
-$3.52B
Cap. Flow %
-1.93%
Top 10 Hldgs %
11.63%
Holding
5,141
New
639
Increased
1,734
Reduced
1,574
Closed
583

Sector Composition

Rank Sector Weight
1 Technology 18.6%
2 Consumer Discretionary 9.12%
3 Healthcare 7.62%
4 Industrials 7.14%
5 Financials 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLO icon
3151
CALL
dLocal
DLO
$4.47B
$1.52M ﹤0.01%
107,200
RRGB icon
3152
Red Robin
RRGB
$151M
$1.52M ﹤0.01%
374,256
-48,461
-11% -$243K
ECAT icon
3153
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.54B
$1.51M ﹤0.01%
98,455
+12,538
+15% +$201K
CG icon
3154
CALL
Carlyle Group
CG
$17.9B
$1.51M ﹤0.01%
25,500
CVLT icon
3155
Commault Systems
CVLT
$5.52B
$1.51M ﹤0.01%
12,010
-60,100
-83% -$8.46M
PNRG icon
3156
PrimeEnergy Resources
PNRG
$302M
$1.5M ﹤0.01%
8,765
+3,353
+62% +$539K
FAF icon
3157
First American
FAF
$7.66B
$1.5M ﹤0.01%
24,374
-20,008
-45% -$1.25M
IMXI icon
3158
International Money Express
IMXI
$370M
$1.5M ﹤0.01%
97,464
-101,040
-51% -$1.52M
CCRN
3159
DELISTED
Cross Country Healthcare
CCRN
$1.49M ﹤0.01%
184,459
-57,858
-24% -$632K
SMG icon
3160
CALL
ScottsMiracle-Gro
SMG
$3.85B
$1.49M ﹤0.01%
25,600
-26,600
-51% -$1.49M
UGI icon
3161
CALL
UGI
UGI
$7.62B
$1.49M ﹤0.01%
39,700
-44,200
-53% -$1.57M
SOLS
3162
PUT
Solstice Advanced Materials
SOLS
$9.93B
$1.48M ﹤0.01%
+30,475
New +$1.43M
SB icon
3163
Safe Bulkers
SB
$778M
$1.48M ﹤0.01%
307,056
-25,000
-8% -$119K
IDR icon
3164
PUT
Idaho Strategic Resources
IDR
$524M
$1.48M ﹤0.01%
36,700
TEN
3165
Tsakos Energy Navigation Ltd
TEN
$1.15B
$1.48M ﹤0.01%
+65,807
New +$1.54M
PRAX icon
3166
CALL
Praxis Precision Medicines
PRAX
$8.9B
$1.47M ﹤0.01%
+5,000
New +$931K
PRAX icon
3167
PUT
Praxis Precision Medicines
PRAX
$8.9B
$1.47M ﹤0.01%
+5,000
New +$931K
PLD icon
3168
Prologis
PLD
$131B
$1.47M ﹤0.01%
11,513
+8,741
+315% +$1.09M
PAGS icon
3169
PUT
PagSeguro Digital
PAGS
$2.63B
$1.47M ﹤0.01%
152,400
BIO icon
3170
Bio-Rad Laboratories Class A
BIO
$9.31B
$1.46M ﹤0.01%
4,830
+1,530
+46% +$477K
ALGM icon
3171
Allegro MicroSystems
ALGM
$7.79B
$1.46M ﹤0.01%
+55,304
New +$1.52M
NBTB icon
3172
NBT Bancorp
NBTB
$2.77B
$1.46M ﹤0.01%
+35,096
New +$1.46M
HAPN
3173
Happen Inc
HAPN
$2.36B
$1.46M ﹤0.01%
76,850
+29,827
+63% +$527K
EMBJ
3174
CALL
Embraer S.A. ADS
EMBJ
$13B
$1.45M ﹤0.01%
+22,600
New +$1.42M
PFBC icon
3175
Preferred Bank
PFBC
$1.26B
$1.45M ﹤0.01%
15,348
-4,594
-23% -$428K

Similar funds

D.E. Shaw & Co's Q4 2025 Portfolio in Review

As of Q4 2025, D.E. Shaw & Co held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
  • D.E. Shaw & Co added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
  • D.E. Shaw & Co's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
  • D.E. Shaw & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
  • D.E. Shaw & Co opened 639 new positions and closed 583 in Q4 2025.
  • D.E. Shaw & Co's portfolio value rose 3% quarter-over-quarter to $182B.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.